Cancer Incidence for Chelsea, Clinton & Midtown Business District, New York (Manhattan) County, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 820.0 | 494.1 | 478.7-509.9 | 433.2 | 529.6 | 506.7-553.5 | 386.8 | 479.3 | 457.4-502.0 |
| Oral cavity and pharynx | 23.6 | 14.1 | 11.7-17.1 | 16.8 | 19.7 | 15.6-24.8 | 6.8 | 8.0 | 5.5-11.5 |
| Esophagus | 5.0 | 3.0 | 1.9-4.6 | 4.0 | 5.2 | 3.1-8.4 | 1.0 | 1.1 | 0.4-3.1 |
| Stomach | 11.6 | 7.2 | 5.4-9.4 | 6.6 | 8.6 | 5.9-12.4 | 5.0 | 5.7 | 3.7-8.8 |
| Colorectal | 64.4 | 39.8 | 35.6-44.6 | 39.0 | 50.1 | 43.1-58.0 | 25.4 | 30.3 | 25.1-36.4 |
| Colon excluding rectum | 42.8 | 26.6 | 23.1-30.5 | 24.8 | 32.5 | 26.9-39.1 | 18.0 | 20.9 | 16.7-26.1 |
| Rectum & rectosigmoid | 21.6 | 13.3 | 10.9-16.2 | 14.2 | 17.6 | 13.7-22.6 | 7.4 | 9.3 | 6.5-13.2 |
| Liver / intrahepatic bile duct | 19.6 | 11.4 | 9.2-14.0 | 14.2 | 16.5 | 12.8-21.2 | 5.4 | 6.3 | 4.1-9.5 |
| Pancreas | 23.0 | 13.9 | 11.5-16.9 | 11.2 | 14.3 | 10.7-18.9 | 11.8 | 13.6 | 10.3-17.8 |
| Larynx | 3.8 | 2.3 | 1.4-3.8 | 3.2 | 3.7 | 2.1-6.4 | 0.6 | 0.8 | 0.1-2.8 |
| Lung and bronchus | 81.2 | 49.5 | 44.8-54.7 | 41.4 | 52.5 | 45.4-60.5 | 39.8 | 46.9 | 40.5-54.1 |
| Melanoma of the skin | 33.6 | 19.1 | 16.3-22.4 | 20.4 | 23.9 | 19.3-29.4 | 13.2 | 15.7 | 11.9-20.4 |
| Female breast | 119.8 | 154.5 | 142.0-167.9 | ||||||
| Cervix uteri | 7.4 | 9.0 | 6.3-12.8 | ||||||
| Corpus uterus and NOS | 32.6 | 40.9 | 34.7-48.0 | ||||||
| Ovary | 11.8 | 15.7 | 11.8-20.6 | ||||||
| Prostate | 110.4 | 131.2 | 120.3-143.1 | ||||||
| Testis | 7.6 | 6.8 | 4.7-9.9 | ||||||
| Urinary bladder (incl. in situ) | 31.8 | 19.8 | 16.8-23.3 | 25.2 | 34.0 | 28.2-40.8 | 6.6 | 7.7 | 5.2-11.1 |
| Kidney and renal pelvis | 20.8 | 12.9 | 10.5-15.8 | 14.6 | 17.7 | 13.8-22.6 | 6.2 | 7.9 | 5.3-11.6 |
| Brain and other central nervous system | 11.4 | 7.2 | 5.3-9.6 | 7.8 | 9.9 | 6.7-14.3 | 3.6 | 4.2 | 2.4-7.0 |
| Thyroid | 33.2 | 18.5 | 15.7-21.8 | 9.4 | 10.5 | 7.6-14.4 | 23.8 | 29.2 | 23.9-35.5 |
| Hodgkin lymphoma | 5.6 | 2.9 | 1.9-4.4 | 3.2 | 3.3 | 1.8-5.8 | 2.4 | 2.5 | 1.2-4.9 |
| Non-Hodgkin lymphomas | 36.0 | 21.1 | 18.1-24.5 | 23.8 | 28.7 | 23.6-34.7 | 12.2 | 13.9 | 10.6-18.2 |
| Myeloma | 11.4 | 6.7 | 5.0-8.8 | 7.0 | 8.5 | 5.9-12.2 | 4.4 | 5.0 | 3.1-7.9 |
| Leukemias | 25.6 | 16.8 | 13.8-20.2 | 15.2 | 20.2 | 15.8-25.7 | 10.4 | 14.2 | 10.3-19.1 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.
